Cargando…

Heterogeneous global health stock and growth: quantitative evidence from 140 countries, 1990–2100

BACKGROUND: In the prevailing economic perspective, health is viewed as a type of capital stock that yields ‘healthy days’ in human society. However, evaluations of this health capital stock are still limited to specific contexts. The primary aim of this study is to measure and forecast the global h...

Descripción completa

Detalles Bibliográficos
Autores principales: Jumbri, Isma Addi, Ikeda, Shinya, Managi, Shunsuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6309060/
https://www.ncbi.nlm.nih.gov/pubmed/30607246
http://dx.doi.org/10.1186/s13690-018-0327-8
_version_ 1783383330882846720
author Jumbri, Isma Addi
Ikeda, Shinya
Managi, Shunsuke
author_facet Jumbri, Isma Addi
Ikeda, Shinya
Managi, Shunsuke
author_sort Jumbri, Isma Addi
collection PubMed
description BACKGROUND: In the prevailing economic perspective, health is viewed as a type of capital stock that yields ‘healthy days’ in human society. However, evaluations of this health capital stock are still limited to specific contexts. The primary aim of this study is to measure and forecast the global health stocks in 140 countries from 1990 to 2100. METHODS: The health capital stock in each country from 1990 to 2015 was estimated using a capital approach. The future health stocks between 2016 and 2100 were forecast using a time-series model. RESULTS: Based on the health stocks from 1990 to 2015, low-income countries have much larger and more rapidly growing health stocks. In the long-term, to 2100, upper-middle income countries, particularly countries in the Middle East and North Africa, exhibit great growth that benefits from the peaks in their youth or working-age populations. Immigration also contributes to health stock growth, as do other factors, e.g., the fertility rate, population ageing, and working-age and youth populations. CONCLUSIONS: Health stock is a vital component of global sustainable development that should be consistently included as a stock-based sustainability index in the evaluations of other capital to accurately measure national wealth and sustainability.
format Online
Article
Text
id pubmed-6309060
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-63090602019-01-03 Heterogeneous global health stock and growth: quantitative evidence from 140 countries, 1990–2100 Jumbri, Isma Addi Ikeda, Shinya Managi, Shunsuke Arch Public Health Research BACKGROUND: In the prevailing economic perspective, health is viewed as a type of capital stock that yields ‘healthy days’ in human society. However, evaluations of this health capital stock are still limited to specific contexts. The primary aim of this study is to measure and forecast the global health stocks in 140 countries from 1990 to 2100. METHODS: The health capital stock in each country from 1990 to 2015 was estimated using a capital approach. The future health stocks between 2016 and 2100 were forecast using a time-series model. RESULTS: Based on the health stocks from 1990 to 2015, low-income countries have much larger and more rapidly growing health stocks. In the long-term, to 2100, upper-middle income countries, particularly countries in the Middle East and North Africa, exhibit great growth that benefits from the peaks in their youth or working-age populations. Immigration also contributes to health stock growth, as do other factors, e.g., the fertility rate, population ageing, and working-age and youth populations. CONCLUSIONS: Health stock is a vital component of global sustainable development that should be consistently included as a stock-based sustainability index in the evaluations of other capital to accurately measure national wealth and sustainability. BioMed Central 2018-12-28 /pmc/articles/PMC6309060/ /pubmed/30607246 http://dx.doi.org/10.1186/s13690-018-0327-8 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Jumbri, Isma Addi
Ikeda, Shinya
Managi, Shunsuke
Heterogeneous global health stock and growth: quantitative evidence from 140 countries, 1990–2100
title Heterogeneous global health stock and growth: quantitative evidence from 140 countries, 1990–2100
title_full Heterogeneous global health stock and growth: quantitative evidence from 140 countries, 1990–2100
title_fullStr Heterogeneous global health stock and growth: quantitative evidence from 140 countries, 1990–2100
title_full_unstemmed Heterogeneous global health stock and growth: quantitative evidence from 140 countries, 1990–2100
title_short Heterogeneous global health stock and growth: quantitative evidence from 140 countries, 1990–2100
title_sort heterogeneous global health stock and growth: quantitative evidence from 140 countries, 1990–2100
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6309060/
https://www.ncbi.nlm.nih.gov/pubmed/30607246
http://dx.doi.org/10.1186/s13690-018-0327-8
work_keys_str_mv AT jumbriismaaddi heterogeneousglobalhealthstockandgrowthquantitativeevidencefrom140countries19902100
AT ikedashinya heterogeneousglobalhealthstockandgrowthquantitativeevidencefrom140countries19902100
AT managishunsuke heterogeneousglobalhealthstockandgrowthquantitativeevidencefrom140countries19902100